Sponsor:
Valcare Medical Ltd.
Code:
NCT06951672
Conditions
Symptomatic Functional MR 3 or Greater
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Not accepted
Interventions
This study will evaluate the safety and functionality of the AMEND™ Trans-Septal System for annuloplasty as a therapy for mitral regurgitation.
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-09. This information was provided to ClinicalTrials.gov by Valcare Medical Ltd. on 2026-01-07.